Business Development Training Course.
14TH - 15TH May 2025 San Diego, CA USA.
22ND - 23RD May 2025 Brussels, Belgium.
08TH - 09TH Oct 2025 Stockholm, Sweden.
15TH - 16TH Oct 2025 Boston, MA USA.
Are you ready to unlock the secrets of successful deal making in the dynamic world of pharma and biotech? Join us for an intensive and practical 2-day course that will equip you with the essential skills and knowledge needed to navigate the complex landscape of licensing, partnerships, and negotiations.
At our course, you will learn from industry experts who have a deep understanding of the valuation approaches, risk assessment methodologies, and deal structuring techniques that are currently shaping the pharma-biotech world. We have carefully designed the agenda to cover all the crucial topics, ensuring that you leave with a comprehensive understanding of the deal-making process.
Enroll now
in "Mastering Deal Making in Pharma & Biotech"
Unlock the power of deal making in the dynamic world of pharma and biotech. Master the strategies, skills, and frameworks essential for successful collaborations.
- Gain Practical Skills
- Our course offers a hands-on approach, providing you with practical tools, templates, and Excel-based valuation models that you can immediately apply in your professional endeavors. Whether you're involved in investment rounds, mergers and acquisitions, licensing deals, or strategic development decisions, this course will equip you with the skills to produce accurate valuations and make informed business decisions.
- Learn from an Expert
- Our course leader, Dimitri F Dimitriou, FRSM, is a renowned authority in dealmaking in the pharma/biotech sector, having 35 years’ experience in both big pharma companies as well as biotechs. Dimitri has been involved in over 200 deals. With vast sector-specific knowledge and experience, Dimitri will guide you through the intricacies of deal making, sharing valuable insights and case studies that will enhance your understanding and confidence in putting together successful deals.
- Network with Peers
- Our course attracts a diverse audience of executives from pharma, biotech, and related industries. This provides a unique opportunity to network, share experiences, and learn from the successes and challenges faced by your peers. Engage in stimulating discussions, forge new connections, and expand your professional network.
Partnering Expertise
Progress Expertise:
Course Leader:
Dimitri F. Dimitriou, FRSM, FRSC, FRSB, FIBMS
Professional Experience
Dimitri has over 35 years’ experience in the pharmaceutical and biotech industry. Over the last 20 years, he is the founder and Managing Director of DyoDelta Biosciences, an advisory company specializing in providing support in putting together corporate collaborations in the Life Sciences.
He has been involved in over 200 pharma/biotech agreements, mostly cross-border transactions and has been a speaker or chairman in 40 conferences.
He is a co-founder and former CEO of ImmuPharma plc, a drug development biotech company listed on AIM of the London Stock Exchange and previously on Euronext in Brussels.
His past roles include Senior Director, Worldwide Business Development at GlaxoSmithKline, where he was responsible for worldwide transactions with a focus on licensing novel products for development and commercialization. He was also the head for transactions in Europe at Bristol-Myers Squibb. Prior to that, he spent 8 years at Procter & Gamble when it had a pharmaceutical division, in senior marketing, R&D, and business development positions and began his career in marketing at Novartis in 1987.
He has 2 degrees from the University of London - a Bachelor’s in Biochemistry from Kings College and a Master’s in Pathology (Faculty of Medicine) from Imperial College Medical School and training in Internal Medicine and Neurology from Harvard Medical School. He is a Fellow of the Royal Society of Medicine, the Royal Society of Chemistry, the Royal Society of Biology, the Institute of Biomedical Science, and a member of the British Pharmacological Society, the British Neuroscience Association, and the British Society for Immunology.
Awards:
Key Topics
This condensed 2-day course provides a comprehensive overview of the key aspects of deal making in the pharma and biotech industry, as well as MedTech and Digital Health. Participants gain valuable insights into the deal-making process, including preparation, due diligence, licensing, IP protection, valuation, negotiation, and relationship management.
Module 1: Introduction to Business Development & Licensing
Organizational models and scope of work in BD&L.
Types of strategic alliances and their pros and cons.
Module 2: Effective Preparation for BD Partnerships
Strategies for successful meetings and managing partner relationships.
Key materials required for effective contacts.
Module 3: Due Diligence and Licensing Deals
Anatomy of licensing deals: in-licensing and out-licensing.
Key stakeholders and the term sheet process.
Module 4: Intellectual Property and Confidentiality
Data sharing and rights within licensing agreements.
Strategic planning for IP protection.
Module 5: Valuation and Negotiation Strategies
Effective negotiation strategies and tactics.
Approach and tools in negotiations.
Module 6: Relationship Management and Closing Remarks
Recap of key takeaways and final thoughts.